好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Prominent Auditory Hallucinations in Behavioral Variant Frontotemporal Dementia Associated with a MAPT Mutation
Aging, Dementia, and Behavioral Neurology
P3 - Poster Session 3 (5:30 PM-6:30 PM)
9-006

To report prominent auditory hallucinations in the context of behavioral variant frontotemporal dementia (bvFTD).

Hallucinations are rare in sporadic and familial FTD, and when present, these are almost always associated with the C9orf72 hexanucleotide expansion and not mutations in MAPT.

Case Report    

The patient is a right-handed woman who had a mutation in MAPT identified clinically when she was asymptomatic.  She has numerous relatives with bvFTD but none experienced hallucinations of any kind. Mild executive and language dysfunction began in her late 40s along with recurrent auditory hallucinations. She perceived three distinct external voices who made threats against her and her family, often stating that they or others will cause harm to her children or grandchildren. She was fearful of leaving her home, stopped working, and had difficulty sleeping and trouble interacting with others in social situations. She did not have any other delusions, paranoid thoughts or mood changes, and maintained insight about the hallucinations. Olanzapine initially improved her symptoms dramatically, but was changed to quetiapine and risperidone. She has been maintained on these two antipsychotic agents over 2 years. The voices continue to be perceived almost daily but are minimally threatening. She is now dependent on others for complex ADLs, has apathy, disinhibition and ritualistic behavior, and is impaired on several neuropsychologic measures. Serial MRI of the brain shows progressive bilateral frontal and temporal atrophy with significant atrophy bilaterally in the insula. FDG-PET scan of the brain shows mild patchy hypometabolism in the bilateral frontal and temporal lobes, with severe bilateral caudate hypometabolism.

Recurrent and persistent auditory hallucinations can occur in bvFTD. The underlying substrate for this feature is likely related to frontosubcortical neural network dysfunction, but considering that this topography is present in most bvFTD patients, the precise mechanism for auditory hallucinations in this patient is unclear.

Authors/Disclosures
Mary Widmeyer, MD (Northshore University Health System)
PRESENTER
No disclosure on file
No disclosure on file
Ralitza H. Gavrilova, MD (Mayo Clinic) Dr. Gavrilova has nothing to disclose.
Julie A. Fields, PhD (Mayo Clinic) The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute.
Leah K. Forsberg, PhD (Mayo Clinic) Ms. Forsberg has nothing to disclose.
Kejal Kantarci, MD (Mayo Clinic) The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Val J. Lowe, MD (Mayo Clinic) Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Bradley F. Boeve, MD, FAAN (Mayo Clinic) Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.